Report: FDA fails to monitor clinical researchers' financial conflicts

The FDA failed to enforce rules that require drug and device firms to detail the financial interests of outside experts who test experimental treatments before companies file for approval, according to a report from the HHS inspector general. The study is based on 118 new-drug applications that the FDA cleared in 2007. An FDA spokeswoman said the agency does not favor examining clinical investigators' financial conflicts prior to trials because they represent only one source of possible bias.

View Full Article in:

Los Angeles Times (tiered subscription model) · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA